Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2025-01-14
• Last 15 days FTD volume: £2.23 M
• Last 3 months FTD volume: £3.6 M
• Last year FTD volume: £3.6 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	£2.55 M	£34.77 M	🇺🇸 USA
Royalty Pharma RPRX	£18.39 M	£28.25 M	🇬🇧 UK
Palatin Technologies PTN	£1.87 M	£3.92 M	🇺🇸 USA
Eli Lilly LLY	£76.39 M	£0.20 B	🇺🇸 USA
AbbVie ABBV	£51.14 M	£0.19 B	🇺🇸 USA
Pfizer PFE	£28.68 M	£0.33 B	🇺🇸 USA
ANI Pharmaceuticals ANIP	£2.34 M	£4.47 M	🇺🇸 USA
Athersys ATHX	£0.09 M	£0.71 M	🇺🇸 USA